((RAIN)) Rainmakers-Island

[westeffer]

Thanks Mike and Rain. As Rain already knows I became interested in the PDC approach to cancer treatment because I had a friend with PHD from MIT and Harvard who invented one of the first PDC compounds as a derivative of chlorophyll. He did some experimenting with it in China and the UK using photo dynamic and sono-dynamic therapy triggers with some success.

This PDC seems much more targeted and is retained over 100 times more in cancer cells than normal cells. It also appears to have dramatic capability to produce reactive oxygen from PDC to kill cancer cells when activated by cold laser while retaining the critical ability to treat again if necessary. In addition it can be used where other methods in stage four patients have failed. There is an 80% recurrence rate with other methods of treatment, but you might note that in the early trials about 40% of the animals treated did not get cancer again when cancer cells were reintroduced by injection so some immune modulation had taken place.

There have been no new therapies for bladder cancer since the late 1990's and these trials can show safety and efficacy rather quickly with stage 4 non muscle invasive patients who have exhausted all other methods. The trials are being held at one of the top bladder cancer centers in the world so word could spread rather quickly if success is experienced. The early trials showed remarkable results with one treatment when the PDC was broken down into reactive oxygen by cold laser with no side affects. This is a $24 billion world wide underserved medical market with significant patient long term suffering. I think this approach is way under priced by the market currently.